ROLE OF HELICOBACTER PYLORI AND HOST GENE POLYMORPHISMS IN GASTRIC CARCINOGENESIS IN A KAZAKHS

Gulmira Kulmambetova, Meruert Kuatbekovna Imanbekova, Akbota M. Aitkulova, Ivan Shtefanov, Абай Каиргожинович Макишев, Ye.M. Ramankulov

2018

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.11134/btp.1.2018.7
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Emerging evidence indicated that common polymorphisms of TNF-α, IL1B, IL10, TP53, CD14, TLR4 genes might impact individual susceptibility to gastric cancer. Moreover, Helicobacter pylori plays an important role, provoking an increased susceptibility to the development of gastric pathologies. However, the results are still inconclusive, and specific alleles vary in different populations. We conducted a study in the Kazakh population of the Northern region of Kazakhstan to identify potential risks or protective associations of SNP with gastric cancer, or H. pylori infection. We analyzed the association of SNPs in TNF-α (rs1800629 G/A), IL1B (rs16944 A/G), IL10 (rs1800872 G/T, rs1800871 G/A, rs1800896 A/C), TP53 (rs1042522 A/G), CD14 (rs2569190 G/A), and TLR4 (rs4986790 A/G, rs4986791 C/T) genes. We included cases with gastric cancer in a hospital-based Kazakh population (158 cases and 181 cancer-free controls). Identification of Helicobacter pylori was carried out by microbiological methods from biopsy specimens. Genotyping of the extended panel of polymorphisms of candidate genes was performed on the Quant Studio 12K Flex (Life Technologies). To estimate relative risk, odds ratio (OR) and 95% confidence interval (CI) were calculated, and P value 0.05 was considered statistically significant. We found that the polymorphisms of TP53 (rs1042522 A/G, OR: 2.32, 95% CI: 1.41-3.82, P-value=0.0009), CD14 (rs2569190 G/A, OR: 0.59, 95% CI: 0.36 - 0.96, P-value=0.035), and TLR4 (rs4986790 A/G, OR: 0.43, 95% CI: 0.19 - 0.95, P-value=0.038) are associated with gastric cancer risk. No significant association was observed between variant genotype polymorphisms of TNF-α, IL1B, IL10, TLR4 (ID: rs4986791) genes and gastric cancer risk. Further analyzes to assess the combined effect of TP53 rs1042522, CD14 rs2569190 and TLR4 rs4986791 and H. pylori infection on GC risk did not reveal significant associations. Our results testify to markers of GC risk among Kazakhs and may be the first step towards new approaches to diagnosis and prognosis in Kazakhstan.